脉搏波传导速度评价阻塞性睡眠呼吸暂停低通气综合征患者动脉僵硬度的研究进展

董志爽; 李光源; 刘文; 孔凡鑫; 王永槐; 马春燕

doi:10.7619/jcmp.20213566

脉搏波传导速度评价阻塞性睡眠呼吸暂停低通气综合征患者动脉僵硬度的研究进展

中国医科大学附属第一医院心血管超声科, 辽宁沈阳, 110001

基金项目:

国家自然科学基金资助项目 81871373

辽宁省沈阳市科技计划项目 20-205-4-014

详细信息

通讯作者:
马春燕, E-mail: mcy_echo@163.com

中图分类号: R543;R445
计量
- 文章访问数: 249
- HTML全文浏览量: 163
- PDF下载量: 17
出版历程
- 收稿日期: 2021-09-02
- 网络出版日期: 2022-03-15
- 发布日期: 2022-03-14

Research progress on evaluation of arterial stiffness by pulse wave velocity in patients with obstructive sleep apnea hypopnea syndrome

Department of Cardiovascular Ultrasound, the First Hospital Affiliated to China Medical University, Shenyang, Liaoning, 110001

摘要

摘要: 阻塞性睡眠呼吸暂停低通气综合征（OSAHS）是一种由上呼吸道塌陷引起睡眠过程中反复呼吸暂停和低通气的睡眠障碍性疾病。OSAHS患者动脉僵硬度增加是动脉粥样硬化疾病的高危因素。脉搏波传导速度（PWV）是检测动脉僵硬度的可靠方法，可为早期筛查动脉粥样硬化疾病提供科学依据。本文对OSAHS与动脉僵硬的关系、PWV检测方法以及PWV在OSAHS患者动脉僵硬检测中的应用进展等方面进行综述。
- 阻塞性睡眠呼吸暂停低通气综合征 /
- 超声 /
- 极速成像 /
- 脉搏波传导速度 /
- 动脉僵硬
Abstract: Obstructive sleep apnea hypopnea syndrome (OSAHS) is a sleep disorder caused by collapse of upper airways, which causes repeated apnea and hypopnea during sleep. Increased arterial stiffness is a high risk factor for atherosclerosis in patients with OSAHS. Pulse wave velocity (PWV) is the reliable method to detect arterial stiffness, which can provide a scientific basis for early screening of atherosclerotic diseases. In this review, the relationship between OSAHS and arterial stiffness, the detection methods of PWV and the application progress of PWV in the detection of arterial stiffness in patients with OSAHS were reviewed.
- obstructive sleep apnea hypopnea syndrome /
- ultrasound /
- ultrafast imaging /
- pulse wave velocity /
- arterial stiffness

HTML全文

参考文献(31)

[1]	何权瀛, 陈宝元. 阻塞性睡眠呼吸暂停低通气综合征诊治指南(2011年修订版)解读[J]. 中华结核和呼吸杂志, 2012, 35(1): 7-8. doi: 10.3760/cma.j.issn.1001-0939.2012.01.006
[2]	BENJAFIELD A V, AYAS N T, EASTWOOD P R, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis[J]. Lancet Respir Med, 2019, 7(8): 687-698. doi: 10.1016/S2213-2600(19)30198-5
[3]	KIM J, LEE S K, YOON D W, et al. Obstructive sleep apnoea is associated with progression of arterial stiffness independent of obesity in participants without hypertension: a KoGES Prospective Cohort Study[J]. Sci Rep, 2018, 8(1): 8152. doi: 10.1038/s41598-018-26587-y
[4]	CUSPIDI C, TADIC M, GHERBESI E, et al. Targeting subclinical organ damage in obstructive sleep apnea: a narrative review[J]. J Hum Hypertens, 2021, 35(1): 26-36. doi: 10.1038/s41371-020-00397-0
[5]	COCCIOLONE A J, HAWES J Z, STAICULESCU M C, et al. Elastin, arterial mechanics, and cardiovascular disease[J]. Am J Physiol Heart Circ Physiol, 2018, 315(2): H189-H205. doi: 10.1152/ajpheart.00087.2018
[6]	PALOMBO C, KOZAKOVA M. Arterial stiffness, atherosclerosis and cardiovascular risk: Pathophysiologic mechanisms and emerging clinical indications[J]. Vascul Pharmacol, 2016, 77: 1-7. doi: 10.1016/j.vph.2015.11.083
[7]	CICCO S, CASTELLANA G, MARRA L, et al. Analysis of aortic remodeling and stiffness in patients with obstructive sleep apnea syndrome: preliminary results[J]. Adv Exp Med Biol, 2018, 1072: 251-255.
[8]	PHILLIPS C L, BUTLIN M, WONG K K, et al. Is obstructive sleep apnoea causally related to arterial stiffness?A critical review of the experimental evidence[J]. Sleep Med Rev, 2013, 17(1): 7-18. doi: 10.1016/j.smrv.2012.03.002
[9]	FERREIRA C B, SCHOORLEMMER G H, ROCHA A A, et al. Increased sympathetic responses induced by chronic obstructive sleep apnea are caused by sleep fragmentation[J]. J Appl Physiol (1985), 2020, 129(1): 163-172. doi: 10.1152/japplphysiol.00811.2019
[10]	ARNAUD C, BOCHATON T, PÉPIN J L, et al. Obstructive sleep apnoea and cardiovascular consequences: Pathophysiological mechanisms[J]. Arch Cardiovasc Dis, 2020, 113(5): 350-358. doi: 10.1016/j.acvd.2020.01.003
[11]	CHEN J, LIN S, ZENG Y M. An update on obstructive sleep apnea for atherosclerosis: mechanism, diagnosis, and treatment[J]. Front Cardiovasc Med, 2021, 8: 647071. doi: 10.3389/fcvm.2021.647071
[12]	MORIN R, GOULET N, MAUGER J F, et al. Physiological responses to hypoxia on triglyceride levels[J]. Front Physiol, 2021, 12: 730935. doi: 10.3389/fphys.2021.730935
[13]	POREDOS P, JEZOVNIK M K. Preclinical carotid atherosclerosis as an indicator of polyvascular disease: a narrative review[J]. Ann Transl Med, 2021, 9(14): 1204. doi: 10.21037/atm-20-5570
[14]	LAURENT S, COCKCROFT J, VAN BORTEL L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications[J]. Eur Heart J, 2006, 27(21): 2588-2605. doi: 10.1093/eurheartj/ehl254
[15]	BEN-SHLOMO Y, SPEARS M, BOUSTRED C, et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17, 635 subjects[J]. J Am Coll Cardiol, 2014, 63(7): 636-646. doi: 10.1016/j.jacc.2013.09.063
[16]	VAN BORTEL L M, LAURENT S, BOUTOUYRIE P, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity[J]. J Hypertens, 2012, 30(3): 445-448. doi: 10.1097/HJH.0b013e32834fa8b0
[17]	VAN HOUT M J, DEKKERS I A, WESTENBERG J J, et al. Normal and reference values for cardiovascular magnetic resonance-based pulse wave velocity in the middle-aged general population[J]. J Cardiovasc Magn Reson, 2021, 23(1): 46. doi: 10.1186/s12968-021-00739-y
[18]	MILAN A, ZOCARO G, LEONE D, et al. Current assessment of pulse wave velocity: comprehensive review of validation studies[J]. J Hypertens, 2019, 37(8): 1547-1557. doi: 10.1097/HJH.0000000000002081
[19]	SALVI P, SCALISE F, ROVINA M, et al. Noninvasive estimation of aortic stiffness through different approaches[J]. Hypertension, 2019, 74(1): 117-129. doi: 10.1161/HYPERTENSIONAHA.119.12853
[20]	ZHU Z Q, CHEN L S, WANG H, et al. Carotid stiffness and atherosclerotic risk: non-invasive quantification with ultrafast ultrasound pulse wave velocity[J]. Eur Radiol, 2019, 29(3): 1507-1517. doi: 10.1007/s00330-018-5705-7
[21]	MARAIS L, PERNOT M, KHETTAB H, et al. Arterial stiffness assessment by shear wave elastography and ultrafast pulse wave imaging: comparison with reference techniques in normotensives and hypertensives[J]. Ultrasound Med Biol, 2019, 45(3): 758-772. doi: 10.1016/j.ultrasmedbio.2018.10.032
[22]	YIN L X, MA C Y, WANG S, et al. Reference values of carotid ultrafast pulse-wave velocity: a prospective, multicenter, population-based study[J]. J Am Soc Echocardiogr, 2021, 34(6): 629-641. doi: 10.1016/j.echo.2021.01.003
[23]	ZHU Z Q, CHEN L S, JIANG X Z, et al. Absent atherosclerotic risk factors are associated with carotid stiffening quantified with ultrafast ultrasound imaging[J]. Eur Radiol, 2021, 31(5): 3195-3206. doi: 10.1007/s00330-020-07405-4
[24]	MINEIRO M A, SILVA P, ALVES M, et al. The role of sleepiness on arterial stiffness improvement after CPAP therapy in males with obstructive sleep apnea: a prospective cohort study[J]. BMC Pulm Med, 2017, 17(1): 182. doi: 10.1186/s12890-017-0518-z
[25]	JOYEUX-FAURE M, TAMISIER R, BOREL J C, et al. Contribution of obstructive sleep apnoea to arterial stiffness: a meta-analysis using individual patient data[J]. Thorax, 2018, 73(12): 1146-1151. doi: 10.1136/thoraxjnl-2018-211513
[26]	GALERNEAU L M, BAILLY S, BOREL J C, et al. Long-term variations of arterial stiffness in patients with obesity and obstructive sleep apnea treated with continuous positive airway pressure[J]. PLoS One, 2020, 15(8): e0236667. doi: 10.1371/journal.pone.0236667
[27]	KIM T, LEE C S, LEE S D, et al. Impacts of comorbidities on the association between arterial stiffness and obstructive sleep apnea in the elderly[J]. Respiration, 2015, 89(4): 304-311. doi: 10.1159/000371768
[28]	ÇÖRTVK M, AKYOL S, BAYKAN A O, et al. Aortic stiffness increases in proportion to the severity of apnoea-hypopnea index in patients with obstructive sleep apnoea syndrome[J]. Clin Respir J, 2016, 10(4): 455-461. doi: 10.1111/crj.12244
[29]	BORSINI E, BLANCO M, BOSIO M, et al. Prevalence of sleep apnea and cardiovascular risk factors in patients with hypertension in a day hospital model[J]. Clin Exp Hypertens, 2018, 40(3): 231-237. doi: 10.1080/10641963.2017.1356841
[30]	VLACHANTONI I T, DIKAIAKOU E, ANTONOPOULOS C N, et al. Effects of continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea in arterial stiffness: a meta-analysis[J]. Sleep Med Rev, 2013, 17(1): 19-28. doi: 10.1016/j.smrv.2012.01.002
[31]	CARDOSO C R L, RODERJAN C N, CAVALCANTI A H, et al. Effects of continuous positive airway pressure treatment on aortic stiffness in patients with resistant hypertension and obstructive sleep apnea: a randomized controlled trial[J]. J Sleep Res, 2020, 29(4): e12990.

施引文献(20)

期刊类型引用(13)

1.	刘倩. 难治性胃食管反流病的中医疗法研究近况. 湖北中医杂志. 2023(11): 63-66 . 百度学术
2.	杨超，陈莉丽，杨振斌. 方晓华抑木扶土法临床运用验案举隅. 中国民间疗法. 2022(14): 105-108 . 百度学术
3.	郭丽，夏军权，刘晓桐. 难治性胃食管反流病中医药诊治研究进展. 光明中医. 2021(22): 3790-3793 . 百度学术
4.	贾军峰，李文萍. 和胃降逆饮联合西药及针刺治疗残胃引起的反流性食管炎的疗效及对血清胃动素的影响. 中国中西医结合消化杂志. 2020(12): 944-948 . 百度学术
5.	刘妍. 疏肝降逆汤联合中医特色护理治疗胃食管反流病效果研究. 药品评价. 2019(01): 44-46 . 百度学术
6.	马雪梅. 和胃降逆汤加减联合奥美拉唑、枸橼酸莫沙必利治疗肝胃郁热型胃食管反流病的临床观察. 中国民间疗法. 2019(05): 55-56 . 百度学术
7.	房晓娜. 和胃降逆汤加减治疗胃食管反流病肝胃郁热型临床观察. 实用中医药杂志. 2019(04): 413-414 . 百度学术
8.	邓粉会. 自拟和胃降逆汤辅助西药治疗胃食管反流病相关性支气管哮喘疗效观察. 人人健康. 2019(24): 114-115 . 百度学术
9.	黄太伟. 半夏厚朴汤加减治疗难治性胃食管反流病的疗效研究. 实用医技杂志. 2018(06): 625-626 . 百度学术
10.	高钟. 泮托拉唑、香砂养胃丸、左金丸联用治疗胃食管反流病的效果观察. 中国社区医师. 2018(19): 102-103 . 百度学术
11.	姚向东. 雷贝拉唑、莫沙必利与玄麦甘桔三联用药治疗咽喉反流疾病的临床疗效. 中国合理用药探索. 2018(02): 8-11 . 百度学术
12.	王巧凤，王胜业. 和胃降逆汤加减治疗肝胃郁热型胃食管反流病疗效观察. 北方药学. 2018(11): 131 . 百度学术
13.	王茜茜，李华岳. 加减乌梅丸方联合穴位针刺对胃食管反流病患者食管动力的影响. 中国中医药现代远程教育. 2018(23): 42-44 . 百度学术